Approximately 1–6% of all cases are classed as early-onset AD, typically with mutations in amyloid-processing genes (APP, PSEN1 and PSEN2) [18], whilst genome wide-association studies (GWAS) have identified numerous risk variant genes associated with late onset Alzheimer’s disease (AD) [19–28]. Here, PSEN2 is linked to Alzheimer disease.